Cardiovascular Ultrasound Market, by Test Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, and Others), by Technology (2D, 3D & 4D, and Doppler Imaging), by Modality (Portable and Standalone), by End User (Hospita

Cardiovascular Ultrasound Market, by Test Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, and Others), by Technology (2D, 3D & 4D, and Doppler Imaging), by Modality (Portable and Standalone), by End User (Hospitals, Ambulatory Care Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

There are different types of heart ultrasound or echocardiogram. The most common type of echo performed is transthoracic echo. This is done by placing an ultrasound probe containing a lubricating gel on the outside of the chest wall to transmit sound waves into the body. Transesophageal Echo is a form of echo that uses a miniature ultrasound camera to pass through the throat and locate the back of the heart. Doppler echocardiography assess the blood flow in the heart and blood vessels. This procedure measures the velocity and direction of blood flow in the heart.

Market Dynamics

Market players are focused on product launches or approvals, which could contribute to the growth of the global cardiovascular ultrasound market over the forecast period. For instance, on October 13, 2021, GE Healthcare, a medical technology company, received USFDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new artificial intelligence (AI)-based features that enable clinicians to consistently acquire faster and more repeatable exams.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, which is expected to drive the growth of the global cardiovascular ultrasound market. For instance, on March 02, 2021, Royal Philips, a global leader in health technology, announced a partnership with DiA Imaging Analysis Ltd., a leading provider of AI-powered applications for ultrasound, to deliver automated solutions to clinicians at the point-of-care. Philips’ industry leading ultrasound image quality combined with DiA’s AI library of automated solutions will help in increasing its diagnostic portfolio, operational efficiency, and access to care for Point-of-Care customers in and out of the hospital.

Market players focused on product launches is expected to propel the growth of the global cardiovascular ultrasound market. For instance, on March 17, 2017, Canon's Toshiba Medical subsidiary announced that its Aplio i900 cardiovascular ultrasound system received USFDA 510(k) clearance and has been launched in the U. S. According to the medical subsidiary based in Tustin, California. The Aplio i900 is intended to allow clinicians to assess myocardial function and complex valvular lesions with greater depth and detail than previous versions.

Key features of the study:
This report provides an in-depth analysis of global cardiovascular ultrasound market, provides market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global cardiovascular ultrasound market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, FUJIFILM Sonosite, Inc., Hitachi Medical Corporation, Samsung Medison Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CHISON Medical Technologies Co., Ltd., ESAOTE SPA, and Canon Medical Systems USA
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global cardiovascular ultrasound market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global cardiovascular ultrasound market

Detailed Segmentation:
Global Cardiovascular Ultrasound Market, By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
Global Cardiovascular Ultrasound Market, By Technology :
2D
3D & 4D
Doppler Imaging
Global Cardiovascular Ultrasound Market, By Modality :
Portable
Standalone
Cardiovascular Ultrasound Market, By End User:
Hospitals
Ambulatory Care Centers
Others
Global Cardiovascular Ultrasound Market, By Region:
North America
By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
By Technology:
2D
3D & 4D
Doppler Imaging
By Modality:
Portable
Standalone
By End User:
Hospitals
Ambulatory Care Centers
Others
By Country:
U.S.
Canada
Latin America
By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
By Technology:
2D
3D & 4D
Doppler Imaging
By Modality:
Portable
Standalone
By End User:
Hospitals
Ambulatory Care Centers
Others

By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
By Technology:
2D
3D & 4D
Doppler Imaging
By Modality:
Portable
Standalone
By End User:
Hospitals
Ambulatory Care Centers
Others
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
By Technology:
2D
3D & 4D
Doppler Imaging
By Modality:
Portable
Standalone
By End User:
Hospitals
Ambulatory Care Centers
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
By Technology:
2D
3D & 4D
Doppler Imaging
By Modality:
Portable
Standalone
By End User:
Hospitals
Ambulatory Care Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type:
Transthoracic Echocardiogram
Transesophageal Echocardiogram
Stress Echocardiogram
Others
By Technology:
2D
3D & 4D
Doppler Imaging
By Modality:
Portable
Standalone
By End User:
Hospitals
Ambulatory Care Centers
Others
By Country/Region:
South Africa
Central Africa
North Africa

Company Profiles
GE Healthcare *
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Koninklijke Philips N.V.
Siemens Healthcare GmbH
FUJIFILM Sonosite, Inc.
Hitachi Medical Corporation
Samsung Medison Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
CHISON Medical Technologies Co., Ltd.
ESAOTE SPA
Canon Medical Systems, USA

“*” marked represents similar segmentation in other categories in the respective section.